Taysha Gene Therapies, Inc. company logo
Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc. (TSHA) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$139.04M$4.90M-3.41%

Summary

Current Value
As of today, TSHA annual cash & cash equivalents is $139.04M, down -3.41% on
Historical Performance
TSHA annual cash & cash equivalents is down -6.75% over the past 3 years, and up +100.00% over the past 5 years
All-Time High Comparison
TSHA annual cash & cash equivalents is currently -44.66% below its historical high of $251.25M set on
3-Year Low Comparison
TSHA annual cash & cash equivalents is +58.21% above its 3-year low of $87.88M reached on an earlier date
Sector Comparison
TSHA annual cash & cash equivalents is higher than 71.19% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TSHA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$139.04M-3.4%-6.8%+100.0%+100.0%
Quarterly Cash & Cash Equivalents$297.79M+88.3%+768.0%+6.9%
Price$5.14+166.3%+155.7%-81.1%
Annual Current Assets$142.13M-5.2%-10.9%+10000.0%+10000.0%
Annual Total Liabilities$204.88M+6.7%+72.8%+10000.0%+10000.0%
Annual Working Capital$115.77M+3.0%+7.9%+10000.0%+10000.0%
Annual Net Income-$89.30M+20.0%+48.8%-7908.8%-7908.8%

Cash and Cash Equivalents Highs

TSHA Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$143.94M-3.4%
5Y$251.25MN/A-44.7%
All$251.25M-44.7%

Cash and Cash Equivalents Lows

TSHA Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$87.88MN/A+58.2%
5Y$87.88M+58.2%
All$0.00N/A

Cash and Cash Equivalents History

YearValueChange
$139.04M-3.4%
$143.94M+63.8%
$87.88M-41.1%
YearValueChange
$149.10M-40.7%
$251.25M>+9,900.0%
$0.00-

FAQ

  • What is the current annual cash & cash equivalents of TSHA?

    As of today, TSHA annual cash & cash equivalents is $139.04M

  • What is 1-year change in TSHA annual cash & cash equivalents?

    TSHA annual cash & cash equivalents is down -3.41% year-over-year

  • What is 3-year change in TSHA annual cash & cash equivalents?

    TSHA annual cash & cash equivalents is down -6.75% over the past 3 years

  • How far is TSHA annual cash & cash equivalents from its all-time high?

    TSHA annual cash & cash equivalents is currently -44.66% below its historical high of $251.25M set on December 31, 2020

  • How does TSHA annual cash & cash equivalents rank versus sector peers?

    TSHA annual cash & cash equivalents is higher than 71.19% of companies in Healthcare sector

  • When is TSHA next annual earnings release?

    The next annual earnings release for TSHA is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. TSHA Official Website www.tayshagtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1806310/000119312525263506/0001193125-25-263506-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806310/000095017025027348/0000950170-25-027348-index.htm
  4. TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
  5. TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha